Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine added to fascia iliaca block for postoperative analgesia after femoral fracture surgery
IRCT20170515033986N4Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Apr 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of dexmedetomidine and bupivacaine in femoral fracture (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Duration of analgesia. Started Apr 2022; status: completed.
02
Drugs
dexmedetomidinebupivacaine
03
Conditions
femoral fracture
Beyond the preview
Go deeper on IRCT20170515033986N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170515033986N4.